Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Chart Of The Day: Vaccine Maker Pfizer Has Good Shot At Heading Higher

By Investing.com (Pinchas Cohen/Investing.com)Stock MarketsJan 06, 2021 09:36AM ET
www.investing.com/analysis/chart-of-the-day-vaccine-maker-pfizer-has-good-shot-at-heading-higher-200549720
Chart Of The Day: Vaccine Maker Pfizer Has Good Shot At Heading Higher
By Investing.com (Pinchas Cohen/Investing.com)   |  Jan 06, 2021 09:36AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Thanks to COVID-19 vaccines, which are expected to help countries manage the pandemic and reopen locked down economies, global stocks have repeatedly posted fresh record highs in recent months. Why then are shares of the actual vaccine makers slumping?

Pfizer (NYSE:PFE), which was the first pharama to roll out their immunization for general use, is down 9.5% over the last four days. Shouldn't shares of the New York City-based company be going through the roof? 

The stock's downward move seems to be another variation of the old market adage, 'buy-the-rumor, sell-the-news.' Since investors bought the stock for its potential, in order to get out ahead of the vaccine's approval and affiliated sales, shares climbed over 50% from the March low to the December high.

PFE Weekly
PFE Weekly

But, beginning the week of Nov. 9, some investors decided to lock in profits and the selling started. A month later, beginning the week of Dec. 7, a second wave occurred, forming a long upper shadowed shooting star, followed by the mother of all Bearish Engulfing patterns, with an even longer red candle during the week that started on Dec. 14.

That's the period when sellers were unwinding positions, driving the price down, as they filled all the present demand, then sought additional, more discerning buyers, at lower prices. Ironically, some investors who sold when the stock was in the $40s may well have repurchased at the mid-to-high $30s.

It’s not the identity or number of people buying or selling that moves the market, but the amount of capital changing hands. Now, however, the distribution of that capital on the supply-demand scale is at a tipping point. And we're identifying an upward bias going forward.

The price has been developing a year-long symmetrical triangle, shaped according to the forces of supply and demand. It’s symmetrical because both sides were pushing at the price.

While the pattern follows a decline since the December 2018 high, it 'just so happens' to have developed where it meets with the advance since the March 2009 bottom, suggesting greater interest in that trend.

While the 50-week MA has been supporting the price for a third week now, the 100-week MA reinforces the triangle’s top, underscoring its significance as a bearish stronghold—and the powerful upside move that could be triggered by its breakout.

As well, the stock has already provided back-to-back upside breakouts, one of which included the downtrend line. Bears may have then pushed the price back down, but the bottom of the pattern held. In fact, it has rebounded this week right off its bottom, demonstrating its technical significance.

The Relative Strength Index (RSI), which measures price momentum, has been forming a bottom, whose upside breakout above 63 would signal a reversal in momentum to the upside.

The Money Flow Index (MFI), which measures the momentum of both price and volume change, supports the rising price, both in the short-term, by trending within its rising channel between the March low and the present, as well as in the long-term, within a rising channel since 2016.

Finally, the price’s position provides a rich, risk-reward ratio, since it's on the very bottom of the pattern. The price objective is $12 from the point of breakout, to an estimated target of $50. 

However, if the price falls below $34.60, we would be concerned the tide may have shifted, with a low below the Mar. 23 bottom putting it in a full-on downtrend.

Trading Strategies

Conservative traders should wait for the price to post a new high, above $43.08, to re-establish the dominance of the long-term uptrend since the 2008 bottom over the medium-term downtrend since the 2018 high.

Moderate traders may be content with a close above the downtrend line, if not the symmetrical triangle.

Aggressive traders may enter a long position now.

Trade Sample

  • Entry: $37
  • Stop-Loss: $36
  • Risk: $1
  • Target: $43
  • Reward: $6
  • Risk:Reward Ratio: 1:6
Chart Of The Day: Vaccine Maker Pfizer Has Good Shot At Heading Higher
 

Related Articles

Chart Of The Day: Vaccine Maker Pfizer Has Good Shot At Heading Higher

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email